Detail
| LncRNA Name | PTCSC3 |
| Synonyms | NA |
| Region | GRCh38_14:36136108-36176468 Sequence |
| Ensembl | ENSG00000259104 |
| RefSeq | NR_049735 |
| Circulating | ✘ |
| Drug-resisitant | ✔ |
| Prognostic | ✘ |
| MiRNA | ✘ |
| Variant | ✘ |
| TF | ✘ |
| Methylation | ✘ |
| Cancer Name | anaplastic thyroid cancer |
| ICD-0-3 | C73 M8020/3 |
| Methods | qPCR, Western blot, RIP, in vitro knockdown etc. |
| Sample | cell lines (FTC 238,FTC 133), ATC and FTC tissues |
| Expression Pattern | down-regulated |
| Function Description | LncRNA PTCSC3 was low-expressed in ATC tissues and cells.Over-expressed PTCSC3 inhibited the drug resistance of ATC to doxorubicin. PTCSC3 negatively regulated STAT3, and STAT3 promoted expression of INO80. PTCSC3 regulated INO80 through STAT3. PTCSC3 suppressed stem cells properties and drug resistance of ATC to doxorubicin.CLncRNA PTCSC3 inhibits INO80 expression by negatively regulating STAT3,and thereby attenuating drug resistance of ATC to chemotherapy drug doxorubicin. |
| Pubmed ID | 29561707 |
| Year | 2018 |
| Title | LncRNA PTCSC3 affects drug resistance of anaplastic thyroid cancer through STAT3/INO80 pathway. |
| External Links |
| Links for PTCSC3 | GenBank HGNC lncrnadb Noncode |
| Links for anaplastic thyroid cancer | Omim Cosmic |
CopyRight © College of Bioinformatics Science and Technology, Harbin Medical University, China.